J. B. Chemicals & Pharmaceuticals Limited Share Price and Company Fundamentals
Last traded: 07/16/2026
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, capsules, liquids, gels, lozenges, creams, injectables, powder, cold rubs, eye drops, and troches; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, the company offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. It provides its products to gastroenterology, anti-infectives, wound care, neonatology and pediatrics, genecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.
Key Metrics
PE ratio
54.22
PB ratio
9.33
Dividend yield
-
Beta
0.01
Market cap
₹387.93B
Enterprise value
₹374.59B
Company profile
| Industry / Sector | / |
|---|---|
| Full time employees | 5602 |
| Website | https://www.jbpharma.com |
| Mailing address | Cnergy IT Park Unit A2, 3rd floor, Unit A, 8th floor Appa Saheb Marathe Marg Prabhadevi Mumbai 400025 India |
| Phone / Fax | 91 22 2439 5200 / 91 22 2431 5331 |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
-
5Y Avg. yield
-%
J. B. Chemicals & Pharmaceuticals Limited paid ₹- dividend and the ex-dividend date was -.The dividend payout ratio is -. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.
Company Executives
As of Sep 2026, following are the company executives and directors listed on J. B. Chemicals & Pharmaceuticals Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Suresh Amin | Assistant Vice President Human Resource | ||
| Mr. Kaushal Singh Solanki CA | Chief Financial Officer | 58 | |
| Mr. Bhagwat Singh Deora | Vice President of Finance & Accounts | 42 | |
| Mr. Suresh Bhise | Vice President of Information & Technology | 58 | |
| Mr. Sridhar Bharadwaj | Vice President of Human Resources & Administration | 57 | |
| Mr. Sandeep Anil Phadnis | Vice President of Secretarial & Company Secretary and Compliance Officer | 56 | |
| Mr. Parmeshwar B. Bang | Executive Vice President of Operations of Daman | 57 | |
| Dr. Alisher Djabbarov | Head of Representative Office - Tashkent & Uzbekistan | ||
| Dr. Sujay Rajhans | President of Research & Development | 48 | |
| Mr. Bharat Dhanani | Executive Vice President of Operations for Ankleshwar & Panoli | 56 |
Profitability and management effectiveness
Profit margin
17.11%
Operating margin
16.48%
Return on assets
12.48%
Return on equity
18.69%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of J. B. Chemicals & Pharmaceuticals Limited is 387.93B and its enterprise value is 374.59B. The enterprise value to revenue ratio of JBCHEPHARM is 9.03. The enterprise value to EBITDA ratio of JBCHEPHARM is 34.34.
The JBCHEPHARM's stocks Beta value is 0.01 making it 99% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Frequently Asked Questions
1. What is J. B. Chemicals & Pharmaceuticals Limited's Stock Symbol?
J. B. Chemicals & Pharmaceuticals Limited trades on NSE under the ticker symbol "JBCHEPHARM".
2. What is J. B. Chemicals & Pharmaceuticals Limited's stock price today?
One share of JBCHEPHARM stock can currently be purchased for approximately ₹2416.1.
3. How can I contact J. B. Chemicals & Pharmaceuticals Limited?
J. B. Chemicals & Pharmaceuticals Limited's mailing address is Cnergy IT Park Unit A2, 3rd floor, Unit A, 8th floor Appa Saheb Marathe Marg Prabhadevi Mumbai 400025 India. The company can be reached via phone at 91 22 2439 5200.
4. What is J. B. Chemicals & Pharmaceuticals Limited's official website?
The official website of J. B. Chemicals & Pharmaceuticals Limited is https://www.jbpharma.com.